OCGN vs OGEN

Ocugen, Inc. vs Oragenics Inc. — Valuation Comparison 2026

OCGN

Biotechnology
Ocugen, Inc.
Quality
6.6
out of 10
Value Trap
26
LOW
Price
$1.41
Last close
Models
8/13
Active
VS

OGEN

Biotechnology
Oragenics Inc.
Quality
4.5
out of 10
Value Trap
12
SAFE
Price
$0.60
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType OCGN Fair ValueOCGN Upside OGEN Fair ValueOGEN Upside
Bayesian DCF Intrinsic $0.40 -71.8% $0.90 +49.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.14 -76.9%
Dynamic NAV Asset-Based $0.22 -84.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for OCGN vs OGEN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OCGN vs OGEN — Which Stock Is More Undervalued?

OCGN scores higher with a 6.6/10 quality rating vs OGEN's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ocugen, Inc. (OCGN) and Oragenics Inc. (OGEN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OCGN currently trades at $1.41 with a QOC of 6.6/10, while OGEN trades at $0.60 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).